Literature DB >> 15718216

Functional symptoms in neurology: management.

J Stone1, A Carson, M Sharpe.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15718216      PMCID: PMC1765682          DOI: 10.1136/jnnp.2004.061663

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

Review 1.  Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.

Authors:  K Kroenke; R Swindle
Journal:  Psychother Psychosom       Date:  2000 Jul-Aug       Impact factor: 17.659

2.  Functional neuroanatomical correlates of hysterical sensorimotor loss.

Authors:  P Vuilleumier; C Chicherio; F Assal; S Schwartz; D Slosman; T Landis
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

Review 3.  "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift?

Authors:  M Sharpe; A Carson
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

4.  What should we say to patients with symptoms unexplained by disease? The "number needed to offend".

Authors:  Jon Stone; Wojtek Wojcik; Daniel Durrance; Alan Carson; Steff Lewis; Lesley MacKenzie; Charles P Warlow; Michael Sharpe
Journal:  BMJ       Date:  2002-12-21

Review 5.  Antidepressant therapy for unexplained symptoms and symptom syndromes.

Authors:  P G O'Malley; J L Jackson; J Santoro; G Tomkins; E Balden; K Kroenke
Journal:  J Fam Pract       Date:  1999-12       Impact factor: 0.493

6.  Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms.

Authors:  H L Crimlisk; K Bhatia; H Cope; A David; C D Marsden; M A Ron
Journal:  BMJ       Date:  1998-02-21

7.  An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study.

Authors:  Laura H Goldstein; Alicia C Deale; Sara J Mitchell-O'Malley; Brian K Toone; John D C Mellers
Journal:  Cogn Behav Neurol       Date:  2004-03       Impact factor: 1.600

  7 in total
  18 in total

Review 1.  Psychogenic movement disorders: a crisis for neurology.

Authors:  Mark Hallett
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 2.  Non-cardiac Chest Pain: A Review for the Consultation-Liaison Psychiatrist.

Authors:  Kirsti A Campbell; Elizabeth N Madva; Ana C Villegas; Eleanor E Beale; Scott R Beach; Jason H Wasfy; Ariana M Albanese; Jeff C Huffman
Journal:  Psychosomatics       Date:  2016-12-09       Impact factor: 2.386

3.  Streamlined classification of psychopathological hand disorders: A literature review.

Authors:  Mary P Eldridge; Brad K Grunert; Hani S Matloub
Journal:  Hand (N Y)       Date:  2007-09-11

4.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

5.  [Functional neurological disorders: update and example of integrated inpatient treatment including mirror therapy].

Authors:  A Joos; R Halmer; N Leiprecht; K Schörner; C Lahmann; C Blahak
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

6.  Limits to truth-telling: neurologists' communication in conversion disorder.

Authors:  Richard Kanaan; David Armstrong; Simon Wessely
Journal:  Patient Educ Couns       Date:  2009-06-27

7.  Medically unexplained neurological symptoms.

Authors:  Hani Marcus; Poppy Aldam; Graham Lennox; Rodney Laing
Journal:  JRSM Short Rep       Date:  2010-08-31

8.  What do patients with medically unexplained physical symptoms (MUPS) think? A qualitative study.

Authors:  José Nunes; Teresa Ventura; Ricardo Encarnação; Patrícia Rosado Pinto; Isabel Santos
Journal:  Ment Health Fam Med       Date:  2013-06

Review 9.  Psychiatric issues in chronic pain.

Authors:  Michael R Clark
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

10.  Functional or psychogenic: what's the better name?

Authors:  Kathrin LaFaver; Mark Hallett
Journal:  Mov Disord       Date:  2014-09-21       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.